Background—Controversy still exists regarding the best endovascular treatment strategy for
patients with symptomatic disease of the superficial femoral artery. There are conflicting data …

Purpose To evaluate longer outcomes of primary nitinol stenting for the treatment of
femoropopliteal lesions up to 15 cm long after these stents were found to have superior short …

Background Because stent implantation for disease of the superficial femoral artery has
been associated with high rates of late clinical failure, percutaneous transluminal …

Background: Recent randomized trials investigating stent implantation compared with
balloon angioplasty for treatment of superficial femoral artery (SFA) disease have given …

Background—Endoluminal treatment of superficial femoral artery lesions is a matter of
controversy. The present study was designed to investigate the impact of nitinol stenting of …

Purpose To determine the safety and efficacy of a new-generation nitinol stent with
enhanced flexibility in arterial lesions in the superficial femoral artery (SFA) and proximal …

OBJECTIVE: Angioplasty and stenting are options for revascularization of symptomatic
femoral popliteal disease. Although angioplasty alone is effective in short lesions, longer …

OBJECTIVES: Over the last decade, the number of endovascular procedures performed on
the superficial femoral (SFA) and popliteal arteries (PA) has significantly increased. There is …

Background—Primary stenting with self-expanding nitinol stents of the superficial femoral
artery yielded improved morphological and clinical results compared with balloon …

Purpose: To evaluate the long-term efficacy and integrity of the PROTÉGÉ EverFlex stent in
superficial femoral artery (SFA) lesions in symptomatic patients with peripheral artery …